NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS
申请人:AstraZeneca AB
公开号:EP1150996A1
公开(公告)日:2001-11-07
US6599894B1
申请人:——
公开号:US6599894B1
公开(公告)日:2003-07-29
[EN] NEW AMIDINOBENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS<br/>[FR] NOUVEAUX DERIVES D'AMIDINOBENZYLAMINE ET LEUR UTILISATION COMME INHIBITEURS DE THROMBINE
申请人:ASTRAZENECA AB
公开号:WO2000042059A1
公开(公告)日:2000-07-20
There is provided compounds of formula (I) wherein R?1, R2 Y, R3 and R4¿ have meanings given in the description which are useful as, or as prodrugs of, competitive inhibitors of trypsin-like proteases, such as thrombin, and in particular in the treatment of conditions where inhibition of thrombin is required (e.g. thrombosis) or as anticoagulants.